Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling
Author:
Publisher
Elsevier BV
Subject
Dermatology,Molecular Biology,Biochemistry
Reference27 articles.
1. Comparing antibody and small-molecule therapies for cancer;Imai;Nat Rev Cancer,2006
2. Cutaneous side-effects of kinase inhibitors and blocking antibodies;Robert;Lancet Oncol,2005
3. Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy;Jatoi;Oncologist,2008
4. Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion;Potthoff;Ann Oncol,2011
5. Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies;Wacker;Clin Cancer Res,2007
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Post-Translational Modifications in Atopic Dermatitis: Current Research and Clinical Relevance;Frontiers in Cell and Developmental Biology;2022-07-07
2. Endoplasmic reticulum stress in human chronic wound healing: Rescue by 4‐phenylbutyrate;International Wound Journal;2020-11-22
3. Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer;Oncotarget;2017-08-02
4. Treatment with phenylbutyrate in a pre-clinical trial reduces diarrhea due to enteropathogenic Escherichia coli: link to cathelicidin induction;Microbes and Infection;2013-11
5. Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET;Nuclear Medicine and Biology;2013-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3